The Hematologic Malignancies Program combines the talents and expertise of outstanding basic scientists, nationally recognized clinical researchers, and translational investigators. The goal of the program is to leverage discoveries from member laboratories into clinical interventions for the treatment of malignant hematologic diseases. Disease specific areas of focus for program members include acute lymphoid
leukemia (ALL), chronic myeloid leukemia (CML) and multiple myeloma (MM)Workshop Program
Day1 Gallery
